PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM

https://storage.unitedwebnetwork.com/files/1099/1db363d48b964e84ae44c2b728f2f213.pdf

Zhiming Ye yezhiming@gdph.org.cn Guangdong Provincial People's Hospital Nephrology Guangzhou

Li Fan fanli@gdph.org.cn Guangdong Provincial People's Hospital Nephrology Guangzhou

Rui Yan yryr1234@126.com The Affiliated Hospital of Guizhou Medical University Nephrology Guizhou

Bicheng Liu liubc64@yahoo.com.cn Institute of Nephrology, Zhong Da Hospital, Southeast University Nephrology Nanjing

Linghui Zhou windyhorse2001@sina.com The First Affiliated Hospital of Xiamen University Nephrology Xiamen

Guangqun Xing gqx99monash@163.com The Affiliated Hospital of Qingdao University Nephrology Qingdao

Wei Zhao zhao4wei2@hotmail.com The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital Drug Clinical Research Center Jinan

Zunsong Wang Wzsong3@163.com The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital Nephrology Jinan

Deguang Wang 706698684@qq.com The Second Hospital of Anhui Medical University Nephrology Hefei

Min Zhang 1842685866@qq.com Liuzhou Workers Hospital Nephrology Liuzhou

Xin Zhang xin.zhang@hengrui.com Jiangsu Hengrui Pharmaceuticals Co., Ltd. Clinical Research Development Shanghai

Xinyu Yang xinyu.yang.xy1@hengrui.com Jiangsu Hengrui Pharmaceuticals Co., Ltd. Clinical Research Development Nanjing

Xue Yang xue.yang@hengrui.com Jiangsu Hengrui Pharmaceuticals Co., Ltd. Clinical Research Development Shanghai

Xueqing Yu yuxueqing@gdph.org.cn Guangdong Provincial People's Hospital Nephrology Guangzhou